Cocoa for cognitive function, mood and cardiovascular function: acute and cumulative effect in younger adults.
The acute and cumulative effect of high-flavanol cocoa vs placebo on cognitive function, mood and cardiovascular function in healthy adults aged 18-40 years: a randomised double-blind placebo-controlled one month trial
National Institute of Integrative Medicine
40 participants
Aug 19, 2013
Interventional
Conditions
Summary
Study aims to investigate the effects of acute and cumulative doses of high-flavanol cocoa on cognitive function, mood, and cardiovascular health in a group of healthy younger adults.
Eligibility
Inclusion Criteria1
- Healthy between 18-40 years of age
Exclusion Criteria8
- Poor comprehension of written and spoken English
- Psychiatric disorder
- Suffering from endocrine or gastrointestinal disorders
- Pregnant or lactating
- Taking antidepressants, antipsychotics, anxiolytics, illicit drugs or any cognitive enhancing drugs
- Undergoing participation in another study
- Suffer from colour blindness or any other severe visual impairment
- Taking anti-coagulants or have bleeding disorders
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants will take one tablet of a cocoa supplement (containing 250 mg polyphenols) after baseline assessment & assessment 2 hours after ingestion (acute) and one tablet of cocoa supplement daily for 4 weeks (cumulative). Calendars including trial information will be provided to patients at baseline. To assess compliance, patients will be instructed to mark each day when they have taken the trial capsules, and bring the calendar and any remaining trial capsules to their next appointment.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12613000626763